Qube Research & Technologies (QRT)’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History
Bought
Maintained
Sold
Other funds holding LABD
HF
IC
JF
XT
TSS
Qube Research & Technologies (QRT)'s LABD Position: Q2 2026 in Review
Qube Research & Technologies (QRT) increased its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 419% in Q2 2026, buying an estimated $323K and bringing the position to 29,680 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #2854.
Qube Research & Technologies (QRT) first reported a position in LABD in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.32M in Q4 2025. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.
- Qube Research & Technologies (QRT) held 29,680 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $229K as of Q2 2026.
- Qube Research & Technologies (QRT) bought 23,961 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2026, an estimated $323K.
- Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2854 holding.
- Qube Research & Technologies (QRT) first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2021 and has held it in 17 quarters since.
- Qube Research & Technologies (QRT)'s Direxion Daily S&P Biotech Bear 3X ETF position peaked at $1.32M in Q4 2025.
- 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.